Immunome, Inc. (IMNM) Earnings
Immunome, Inc. is expected to report next earnings on August 5, 2026 (in NaN days), with a consensus EPS estimate of $-0.54. IMNM has beaten EPS estimates in 4 of its last 12 reported quarters (average surprise -1.4% over the last four).
Next earnings
Aug 5, 2026in NaN days
EPS est $-0.54 · Revenue est $166667
Track record
Beat EPS in 4 of 12 quarters
Avg surprise -1.4% (last 4 quarters)
Earnings history
| Report date | EPS est | EPS actual | Surprise | Revenue | Rev. surprise |
|---|---|---|---|---|---|
| May 12, 2026 | $-0.60 | $-0.48 | +20.0% | — | — |
| Mar 3, 2026 | $-0.65 | $-0.75 | -15.4% | — | — |
| Nov 6, 2025 | $-0.57 | $-0.65 | -14.0% | — | — |
| Aug 6, 2025 | $-0.52 | $-0.50 | +3.8% | $4M | +381.8% |
| Mar 19, 2025 | $-0.68 | $-0.84 | -23.5% | $3M | -13.0% |
| Nov 9, 2023 | $-0.17 | $-0.36 | -111.8% | $4M | +0.0% |
| May 5, 2023 | $0.59 | $-0.35 | -159.3% | $2M | — |
| Mar 16, 2023 | $0.67 | $-0.64 | -195.5% | — | — |
| Nov 14, 2022 | $-0.76 | $-0.75 | +1.3% | — | — |
| Aug 5, 2022 | $-0.75 | $-0.74 | +1.3% | — | — |
| May 12, 2022 | $-0.69 | $-0.96 | -39.1% | — | — |
| Nov 15, 2021 | $-0.50 | $-0.65 | -30.0% | — | — |
Source: company filings + earnings calendar. For informational purposes only — not investment advice.